文献速递垂体与肾上腺疾病性腺与生殖内分泌

内源性雌激素调节绝经后女性生长抑素诱导的生长激素反跳分泌

Endogenous Estrogen Regulates Somatostatin-Induced Rebound GH Secretion in Postmenopausal Women.
PubMed 文献 · J Clin Endocrinol Metab · 2016-07-26

在60名健康绝经后女性中开展随机双盲对照研究,分别给予双重安慰剂、阿那曲唑和/或氟维司群。阿那曲唑使雌二醇从3.1 ± 0.35 pg/mL降至0.36 ± 0.04 pg/mL(P < .001),两种雌激素剥夺方案均使生长抑素输注后1小时GH反跳峰值显著下降(P < .001),提示绝经后低水平内源性雌激素参与下丘脑-垂体GH调控。

要点

  • 阿那曲唑使雌二醇从3.1 ± 0.35 pg/mL降至0.36 ± 0.04 pg/mL(P < .001)。
  • 两种雌激素剥夺方案均使生长抑素输注后1小时GH反跳峰值显著下降(P < .001)。
  • GH反跳指标与CT估计的腹部内脏脂肪呈负相关(均P < .05)。

核心结论

  • 数据提示绝经后下丘脑-垂体GH调节存在此前未认识到的对低水平内源性雌激素的依赖。

研究设计与样本

  • 随机双盲对照研究,纳入60名健康绝经后女性,地点为Mayo临床与转化科学中心。
  • 干预分组包括:双重安慰剂、阿那曲唑(芳香化酶抑制剂)和/或氟维司群(选择性雌激素受体-α拮抗剂)。
  • 通过短期静脉生长抑素输注前后频繁采血量化GH脉冲生成。

主要发现

  • 阿那曲唑使雌二醇从3.1 ± 0.35 pg/mL降至0.36 ± 0.04 pg/mL,雌酮从13 ± 1.4 pg/mL降至1.9 ± 0.01 pg/mL(P < .001,质谱法)。
  • 氟维司群未改变雌激素值,睾酮浓度未变化。
  • 生长抑素输注后1小时GH反跳峰值在两种雌激素剥夺方案中均显著下降(P < .001)。
  • 平均(150分钟)最大GH反跳呈可比性下降(P < .001)。
  • GH反跳指标与CT估计的腹部内脏脂肪呈负相关(均P < .05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Systemic concentrations of T, estradiol (E2), GH, IGF-1, and IGF binding protein-3 decline in healthy aging individuals. Conversely, T and E2 stimulate GH and IGF-1 production in hypogonadal patients. HYPOTHESIS: Because E2 stimulates GH secretion, putatively via the nuclear estrogen receptor-α and E2 and GH fall with menopause, we postulated that diminished endogenous E2 contributes to low GH output in older women. LOCATION: The study was conducted at the Mayo Center for Clinical and Translational Science. STUDY DESIGN: This was a randomized, double-blind, controlled study in 60 healthy postmenopausal women treated with the following: 1) double placebo; 2) anastrozole, a potent inhibitor of aromatase-enzyme activity, which mediates E2 synthesis from T; and/or 3) fulvestrant, a selective estrogen receptor-α antagonist. METHODS: GH pulse generation was quantified by frequent GH sampling before and after short-term iv somatostatin infusion, thought to induce hypothalamic GHRH-mediated rebound-like GH secretion. RESULTS: On anastrozole, E2 fell from 3.1 ± 0.35 pg/mL to 0.36 ± 0.04 pg/mL, and estrone from 13 ± 1.4 pg/mL to 1.9 ± 0.01 pg/mL (P < .001) by mass spectrometry. Estrogen values were unchanged by fulvestrant. T concentrations did not change. One-hour peak GH rebound after somatostatin infusion declined markedly during both estrogen-deprivation schedules (P < .001). Mean (150 min) maximal GH rebound decreased comparably (P < .001). Measures of GH rebound correlated negatively with computed tomography-estimated abdominal visceral fat (all P < .05). CONCLUSION: These data suggest a previously unrecognized dependence of hypothalamo-pituitary GH regulation on low levels of endogenous estrogen after menopause.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Veldhuis JD, Erickson D, Yang R, et al. Endogenous Estrogen Regulates Somatostatin-Induced Rebound GH Secretion in Postmenopausal Women. J Clin Endocrinol Metab. 2016. PMID: 27459535

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。